Max Strength Cold & Flu Day & Night

Phenylephrine Hydrochloride, Paracetamol and Caffeine, the active ingredients in Max Strength Cold & Flu Day & Night, are a combination analgesic/antipyretic/decongestant presented as a tablet for oral use. The decongestant reduces swelling of nasal passages, the analgesic/antipyretic lowers temperature and eases aches, and caffeine adds mild stimulation to counteract drowsiness, providing day‑and‑night relief of common cold and flu symptoms in adults.

GNH USA supplies Max Strength Cold & Flu Day & Night as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Max Strength Cold & Flu Day & Night, a combination analgesic/antipyretic/decongestant, is indicated for symptomatic relief of common cold and influenza. - Nasal congestion: reduces swelling of nasal mucosa and improves airflow. - Fever: lowers elevated body temperature. - Pain and aches: alleviates headache, sore throat, and muscle discomfort.

Common Side Effects: - Nausea: mild stomach upset may occur. - Dizziness: transient light‑headedness reported. - Insomnia: difficulty sleeping, especially with the day formulation. - Dry mouth: reduced salivation.

Serious or Rare Side Effects: - Severe allergic reaction (anaphylaxis): rash, swelling, breathing difficulty. - Elevated blood pressure: significant rise in systolic or diastolic pressure.

Before using this product, consider the following precautions: - Pregnancy: consult a healthcare professional before use. - Breastfeeding: use only if the benefits outweigh potential risks. - Hypertension: avoid or use under medical supervision due to phenylephrine. - Liver disease: limit use because of paracetamol content. - Concomitant MAO inhibitors: avoid because of caffeine interaction. - Store at ambient temperature: keep in the original container, protect from moisture and heat.

Max Strength Cold & Flu Day & Night may interact with other medicines as follows: Major Interactions (Avoid): - Monoamine oxidase inhibitors (MAOIs): risk of hypertensive crisis with caffeine. - Other sympathomimetic decongestants (e.g., pseudoephedrine): additive vasoconstrictive effects. - Additional paracetamol‑containing products: risk of hepatic overdose. Moderate Interactions (Monitor Closely): - Beta‑blockers: may diminish phenylephrine’s decongestant effect. - Antihypertensive agents: phenylephrine may counteract blood‑pressure control. - CYP1A2 inhibitors (e.g., fluvoxamine): may increase caffeine levels.